OBSERVATIONAL STUDY OF CHILDREN REQUIRING CRITICAL CARE AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY FOR REFRACTORY/ RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Ramanathan, G. [1 ]
Gupta, C. [1 ]
Bonney, D. [1 ]
机构：
[1] Royal Manchester Childrens Hosp, Manchester, Lancs, England
来源：
PEDIATRIC CRITICAL CARE MEDICINE | 2022年 / 23卷 / 11期
关键词：
Acute Lymphoblastic Leukemia; Critical Care; immunomodulatory therapy;
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
PP070
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Chimeric Antigen Receptor T-Cell Therapy for T-Cell Acute Lymphocytic Leukemia
    Aldoss, Ibrahim
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2025, 23 (01) : 28 - 29
  • [42] Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
    Jiang, Huiwen
    Hu, Yu
    Mei, Heng
    BIOMARKER RESEARCH, 2020, 8 (01)
  • [43] Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
    Huiwen Jiang
    Yu Hu
    Heng Mei
    Biomarker Research, 8
  • [44] Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma
    Korell, Felix
    Schubert, Maria-Luisa
    Sauer, Tim
    Schmitt, Anita
    Derigs, Patrick
    Weber, Tim Frederik
    Schnitzler, Paul
    Mueller-Tidow, Carsten
    Dreger, Peter
    Schmitt, Michael
    CANCERS, 2021, 13 (07)
  • [45] Chimeric antigen receptor T-cell therapy in acute myeloid leukemia
    Koedam, Jan
    Wermke, Martin
    Ehninger, Armin
    Cartellieri, Marc
    Ehninger, Gerhard
    CURRENT OPINION IN HEMATOLOGY, 2022, 29 (02) : 74 - 83
  • [46] Kinetics of immune reconstitution after anti-CD19 chimeric antigen receptor T cell therapy in relapsed or refractory acute lymphoblastic leukemia patients
    Wang, Ying
    Li, Hujun
    Song, Xuguang
    Qi, Kunming
    Cheng, Hai
    Cao, Jiang
    Shi, Ming
    Yan, Zhiling
    Jing, Guangjun
    Pan, Bin
    Sang, Wei
    Wang, Xiangmin
    Zhao, Kai
    Chen, Chong
    Chen, Wei
    Zheng, Junnian
    Li, Zhenyu
    Xu, Kailin
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (02) : 250 - 258
  • [47] CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
    Maude, Shannon L.
    Teachey, David T.
    Porter, David L.
    Grupp, Stephan A.
    BLOOD, 2015, 125 (26) : 4017 - 4023
  • [48] Cluster of differentiation 19 chimeric antigen receptor T-cell therapy in pediatric acute lymphoblastic leukemia
    Fu, Zexin
    Zhou, Jinlei
    Chen, Rui
    Jin, Yihua
    Ni, Ting
    Qian, Lingbo
    Xiao, Chi
    ONCOLOGY LETTERS, 2020, 20 (04)
  • [49] Chimeric antigen receptor T-cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia
    Moskop, Amy
    Pommert, Lauren
    Thakrar, Pooja
    Talano, Julie
    Phelan, Rachel
    PEDIATRIC BLOOD & CANCER, 2021, 68 (01)
  • [50] Granulocyte Transfusions in a Patient with Relapsed B-Cell Acute Lymphoblastic Leukemia Status Post Chimeric Antigen Receptor T-Cell Therapy
    Briski, Laurence M.
    Siegfried, Barry
    Yamada, Chisa
    TRANSFUSION, 2017, 57 : 173A - 174A
12345